Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Scand J Immunol ; 84(5): 262-271, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27607184

ABSTRACT

Tryptophan degradation along the kynurenine pathway is of central importance for the immune function. Toll-like receptors (TLRs), representing the first line of immune defence against pathogens, are expressed in various cell types. The most abundant expression is found on monocytes, macrophages and dendritic cells. The aim of this study was to investigate whether stimulation with different TLR ligands induces the kynurenine pathway in human peripheral monocytes. Cell supernatants were analysed using a liquid chromatography/mass spectrometry to measure kynurenine, kynurenic acid (KYNA), quinolinic acid (QUIN) and tryptophan. Stimulation of TLR-2, TLR-3, TLR-4, TLR-7/8 and TLR-9 was found to induce the production of kynurenine, but only stimulation of TLR-3 increased levels of further downstream metabolites, such as KYNA and QUIN. Stimulation of TLR-1, TLR-5 and TLR-6 did not induce the kynurenine pathway. Taken together, this study provides novel evidence demonstrating that TLR activation induces a pattern of downstream tryptophan degradation along the kynurenine pathway in monocytes. The results of this study may implicate that TLRs can be used as new drug targets for the regulation of aberrant tryptophan metabolism along this pathway, a potential therapeutic strategy that may be of importance in several disorders.


Subject(s)
Kynurenine/immunology , Monocytes/immunology , Toll-Like Receptors/immunology , Tryptophan/immunology , Flagellin/pharmacology , Gene Expression Regulation , Humans , Hydrolysis , Imidazoles/pharmacology , Kynurenic Acid/immunology , Kynurenic Acid/metabolism , Kynurenine/agonists , Kynurenine/metabolism , Lipopeptides/pharmacology , Lipopolysaccharides/pharmacology , Listeria monocytogenes/chemistry , Monocytes/cytology , Monocytes/drug effects , Poly I-C/pharmacology , Primary Cell Culture , Protein Isoforms/agonists , Protein Isoforms/genetics , Protein Isoforms/immunology , Quinolinic Acid/immunology , Quinolinic Acid/metabolism , Signal Transduction , Toll-Like Receptors/agonists , Toll-Like Receptors/genetics , Tryptophan/metabolism
2.
Inflammopharmacology ; 20(3): 169-76, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22237484

ABSTRACT

BACKGROUND: Immune activation induces a pro-inflammatory state, which enhances the tryptophan degradation into kynurenine (KYN). The involvement of kynurenines has been shown in patients with major depression. Here, the effects of anti-inflammatory medication and antidepressants on cytokines and tryptophan metabolite changes in blood culture with immune challenge [bacterial mimetic lipopolysaccharide (LPS)] were investigated. MATERIALS AND METHODS: A total of 21 depressed patients and 38 matched controls were recruited. Whole blood cultures were stimulated with LPS and drugs were added (celecoxib, venlafaxine, reboxetine, imipramine and fluoxetine). Cytokines and kynurenines were analysed. RESULTS: After stimulation with LPS, the interferon-γ and interleukin (IL)-10 secretions were significantly higher in controls than in patients (p = 0.045, p = 0.032), respectively. Adding imipramine and celecoxib abolished the significance for IL-10. Challenge with LPS induced the kynurenine pathway in each group. Regarding the ratio KYNA/KYN, which indicated how much of KYN formed is further catabolised into the neuroprotective arm, the controls' blood cultures showed a significantly higher ratio (p = 0.045). DISCUSSION: Stimulation with LPS induced increased production of pro-inflammatory and anti-inflammatory cytokines in both groups, but higher responses in controls. This lower production of cytokine responses in depressed patients indicates that their immune cells are in a refractory phase, induced by a pre-existing pro-inflammatory state. For kynurenines, the whole metabolism was enhanced by LPS; however, an imbalance to neuroprotective metabolites was observed just in control blood. A drug effect could only be shown for imipramine and celecoxib, which were beneficial in terms of re-balancing the immune function but not in re-balancing neuroactive metabolites.


Subject(s)
Antidepressive Agents/pharmacology , Blood Cells/drug effects , Blood Cells/metabolism , Cyclooxygenase 2 Inhibitors/pharmacology , Cytokines/metabolism , Depressive Disorder, Major/blood , Kynurenine/metabolism , Adult , Antidepressive Agents/blood , Blood Cells/immunology , Cells, Cultured , Cytokines/agonists , Cytokines/blood , Female , Humans , Kynurenine/agonists , Kynurenine/blood , Lipopolysaccharides/blood , Lipopolysaccharides/pharmacology , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL